May 15, 2008 - New research conducted at Moores Cancer Center at University of California, San Diego shows that the SAVI breast brachytherapy applicator, a new approach for delivering accelerated partial breast irradiation (APBI), may provide better protection of healthy tissue than other partial breast irradiation methods.

The research team, led by Catheryn Yashar, M.D., assistant professor and chief of breast and gynecological services in the UC San Diego Department of Radiation Oncology, presented study results at the recent 2008 World Congress of Brachytherapy.

May 15, 2008 – Respironics Inc. and Children’s Medical Ventures, a subsidiary of Respironics, Inc., announced the addition of the BiliTx Phototherapy System to its line of jaundice management products for use by clinicians in the NICU, PICU, pediatrics and nursery or by parents through home care providers.

The BiliTx (abbreviation for bilirubin treatment) Phototherapy System features a highly compact design, multiple therapy configurations and a blue LED photon engine light source that meets the American Association of Pediatrics’ phototherapy guidelines.

May 15, 2008 - Children's Medical Center Dallas, along with its research partner, UT Southwestern, will be participating in a study to test the effectiveness of Lorazepam as compared to Diazepam, two drugs commonly used to treat prolonged or repeated seizures in children.

Researchers from the Perot Center for Brain and Nerve Injury at Children's will be conducting a trial on the drug therapies.

May 15, 2008 – Everbrite Lighting Technologies (ELT) has released its newest environmentally friendly lighting product - the MedLux XLS II light fixture, featuring MRI-safe, recessed, light-emitting diode (LED) light fixtures.

The new LED fixture is designed to be a brighter and more energy-efficient lighting system, using less than 60 watts of electrical energy to deliver 50 foot candles of light at task level, equivalent to the amount of light produced by a 150 watt incandescent light fixture.

The MedLux XLS II will be available starting in July 2008.

May 14, 2008 — In women at increased risk for breast cancer, adding a screening ultrasound examination to routine mammography revealed 78 percent of cancers versus 50 percent of cancers for mammography alone.